Alumis
Antonia Simien's work experience begins in 2001 with their role as a Customer Development Coordinator at OTN, where they coordinated and facilitated training courses for oncology nurses. Antonia stayed in this role until 2004.
In 2007, Antonia joined Genentech as a Procurement Specialist and was responsible for resolving accounts payable inquiries, training new team members, and assisting vendors and internal employees with invoice reconciliation and purchase orders. In 2010, they transitioned to the role of Sr. Administrative Associate, where they maintained complex calendars, coordinated candidate interviews, and supported high-level confidential meetings. Antonia also organized a global oncology event in 2014.
Antonia then took on the role of Assoc. Project Coordinator Rotation in 2016, where they coordinated governance meetings, created executive summaries, and planned and coordinated meetings for study teams. In 2017, they moved on to the position of Project Coordinator and continued their responsibilities in coordinating meetings and executive summaries, while also onboarding new partner organizations. Antonia held this role until 2018.
From 2018 to 2020, Antonia worked as a Project Manager at Genentech, overseeing project coordination and ensuring smooth operations. In 2020, they were promoted to Sr. Business Manager and in 2021, they became the Principal Business Manager. In these roles, Antonia focused on strategic planning, talent and culture development, and managing internal and external communications.
Antonia's most recent position is as the Associate Director of Portfolio Management at Alumis, starting in September 2022.
Antonia Simien holds a PMP Certificate in Project Management from the University of California, Berkeley, which was obtained from 2017 to 2022. They also completed a Master of Arts (M.A.) in Criminal Justice and Corrections from Arizona State University from 2010 to 2012. Antonia also earned a Bachelor's degree in Public Policy, Development, and Management from the University of Southern California from 2005 to 2007. Additionally, Antonia obtained a certification in Project Management Simplified from LinkedIn in 2016.
Alumis
2 followers
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects. Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction. Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.